An NAD
Abstract
Loss of skeletal muscle mass is a major driver of frailty and disability, yet how systemic metabolic cues protect muscle integrity remains unclear. We identify Serpina3n, an adipose-derived adipokine, as a key mediator of the protective effects of nicotinamide adenine dinucleotide (NAD
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Serpina3n is an adipose-derived adipokine that mediates the protective effects of NAD+ supplementation on skeletal muscle integrity. This paper is relevant because it identifies a specific systemic metabolic mechanism (an adipokine) through which NAD+ precursors, a major class of longevity interventions, prevent age-related muscle loss (sarcopenia), thereby addressing a root cause of frailty rather than just treating symptoms.
Author of this paper? Send a correction.